Comparative Study between Primary Percutaneous Coronary Intervention, Pharmacoinvasive Strategy and Pharmacological Reperfusion Strategy in Acute Myocardial Infarction. A Long-Term Follow-Up Analysis
Ammar, A., El Sayed, A., Mohammad, M., Mohammed, M. (2022). Comparative Study between Primary Percutaneous Coronary Intervention, Pharmacoinvasive Strategy and Pharmacological Reperfusion Strategy in Acute Myocardial Infarction. A Long-Term Follow-Up Analysis. EKB Journal Management System, 88(1), 2805-2811. doi: 10.21608/ejhm.2022.242269
Ahmed Shafie Ammar; Ahmed Fathy Ahmed El Sayed; Mohammad Gouda Mohammad; Mostafa Fathy Mohammed. "Comparative Study between Primary Percutaneous Coronary Intervention, Pharmacoinvasive Strategy and Pharmacological Reperfusion Strategy in Acute Myocardial Infarction. A Long-Term Follow-Up Analysis". EKB Journal Management System, 88, 1, 2022, 2805-2811. doi: 10.21608/ejhm.2022.242269
Ammar, A., El Sayed, A., Mohammad, M., Mohammed, M. (2022). 'Comparative Study between Primary Percutaneous Coronary Intervention, Pharmacoinvasive Strategy and Pharmacological Reperfusion Strategy in Acute Myocardial Infarction. A Long-Term Follow-Up Analysis', EKB Journal Management System, 88(1), pp. 2805-2811. doi: 10.21608/ejhm.2022.242269
Ammar, A., El Sayed, A., Mohammad, M., Mohammed, M. Comparative Study between Primary Percutaneous Coronary Intervention, Pharmacoinvasive Strategy and Pharmacological Reperfusion Strategy in Acute Myocardial Infarction. A Long-Term Follow-Up Analysis. EKB Journal Management System, 2022; 88(1): 2805-2811. doi: 10.21608/ejhm.2022.242269

Comparative Study between Primary Percutaneous Coronary Intervention, Pharmacoinvasive Strategy and Pharmacological Reperfusion Strategy in Acute Myocardial Infarction. A Long-Term Follow-Up Analysis

The Egyptian Journal of Hospital Medicine
Article 83, Volume 88, Issue 1, July 2022, Page 2805-2811  XML PDF (653.34 K)
DOI: 10.21608/ejhm.2022.242269
View on SCiNiTO View on SCiNiTO
Authors
Ahmed Shafie Ammar; Ahmed Fathy Ahmed El Sayed; Mohammad Gouda Mohammad; Mostafa Fathy Mohammed*
Department of Cardiology, Faculty of Medicine, Zagazig University, Zagazig, Egypt
Abstract
Background: Until now there is no clear evidence to support the superiority of one strategy over the others to treat STEMI patients.Serial B‐type natriuretic peptide (BNP) measurements accurately predict the risk of death or congestive heart failure in STEMI patients.
Objective: The aim of the study was to determine which strategy is the best strategy to treat acute STEMI and if BNP give an incremental prognostic value in treated STEMI patients.Patients presented with acute STEMI were enrolled in the present study.
Patients and methods: Only 93 patients were followed up with us for 6 months and divided to 3 groups according to the treatment strategy. All patient underwent BNP analysis, echocardiography and treated with either received only thrombolytic therapy (Group I), primary PCI (Group II) or received thrombolytic therapy then went to catheterization (Group III).
Results: Regarding BNP level change was higher in Group I and in Group III had high BNP level higher than Group II but this difference doesn`t reach level for statistically significant correlation between BNP levels and type of reperfusion in the three groups. Regarding LV systolic function, there was no statistically difference between the percent change in LV systolic function in Group I and Group III (P-value = 0.854, 0.152 respectively) but there was statistically significant difference between the percent change in LV systolic function in Group II (P-value=0.031).
Conclusion: The best way for treatment of acute STEMI patients, is a primary PCI the most significant predictive methods are recovery of EF% and reduction of BNP, however pharmacoinavsive strategy like PCI strategy has good follow up prognosis and better than thrombolytic alone therapy.
Statistics
Article View: 335
PDF Download: 455